Immune Therapeutics Stock Filter Stocks by Fundamentals
IMUNDelisted Stock | USD 0.06 0 4.76% |
Immune Therapeutics fundamentals help investors to digest information that contributes to Immune Therapeutics' financial success or failures. It also enables traders to predict the movement of Immune Pink Sheet. The fundamental analysis module provides a way to measure Immune Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immune Therapeutics pink sheet.
Immune |
Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
All Next | Launch Module |
Immune Fundamentals
Return On Asset | -0.45 | |||
Current Valuation | 83.25 M | |||
Shares Outstanding | 82.76 M | |||
Shares Owned By Insiders | 29.51 % | |||
Price To Earning | 333.33 X | |||
Price To Sales | 161.50 X | |||
Gross Profit | 65.83 K | |||
EBITDA | 3.8 M | |||
Net Income | 3.59 M | |||
Cash And Equivalents | 271.53 K | |||
Total Debt | 1.08 M | |||
Debt To Equity | 1.97 % | |||
Current Ratio | 0.04 X | |||
Book Value Per Share | (0.03) X | |||
Cash Flow From Operations | (231.72 K) | |||
Earnings Per Share | 0.03 X | |||
Number Of Employees | 15 | |||
Beta | 0.52 | |||
Market Capitalization | 39.1 M | |||
Total Asset | 3.14 M | |||
Retained Earnings | (319.86 M) | |||
Working Capital | (7.47 M) | |||
Current Asset | 22 K | |||
Current Liabilities | 7.49 M | |||
Net Asset | 3.14 M |
About Immune Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immune Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immune Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immune Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immune Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immune Therapeutics' short interest history, or implied volatility extrapolated from Immune Therapeutics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Immune Pink Sheet
If you are still planning to invest in Immune Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immune Therapeutics' history and understand the potential risks before investing.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |